Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 11, 2012, Pages 815-819

  Davies, Bethany S ^a   Roberts, Catherine H ^a   Kaul, Sunny ^b   Klein, John L ^a   Milburn, Heather J ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Kansasii; Mycobacterial; Non tuberculous; Pulmonary

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFABUTIN; RIFAMPICIN;

ABDOMINAL CRAMP; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COLITIS; DIARRHEA; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART ARREST; HEPATITIS; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM XENOPEI; NAUSEA; NONHUMAN; OPTIC NEURITIS; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ANTIBIOTICS, ANTITUBERCULAR; FEMALE; HUMANS; LONDON; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM KANSASII; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84867796908     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.694469     Document Type: Article

References (19)

1. Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA. Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev 1996;6:R147 - 51.
2. McGarvey J, Bermudez LE. Pathogenesis of mycobacterial infections. Clin Chest Med 2002;23:569 - 83.
3. Grange JM, Yates MD. Infections caused by opportunist mycobacteria: a review. J R Soc Med 1986;79:226 - 9.
4. Field SK, Cowie RL. Lung disease due to more common non-tuberculous mycobacteria. Chest 2006;129:1653 - 72.
5. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210 - 8.
6. ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367 - 416.
7. Standards Unit, Evaluations and Standards Laboratory. National Standard Method: Investigation of specimens for Mycobacterium species. London: Health Protection Agency; 2006. Available from: http://www.hpa.org.uk/webc/HPA webfile/HPAweb-C/1317132693180 (accessed 12 August 2009).
8. Brown-Elliott BA, Griffi th DE, Wallace RJ. Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med 2002; 22:911 - 25.
9. Somoskovi A, Mester J, Hale YM, Parsons LM, Salfi nger M. Laboratory diagnosis of nontuberculous mycobacteria. Clin Lab Med 2002;23:585 - 97.
10. Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006;28:1211 - 5.
11. Andr é jak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009;64:291 - 6.
12. Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 2009;33:148 - 52.
13. Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155: 2041 - 6.
14. Jeong YJ, Lee KS, Koh WJ, Han J, Kim TS, Kwon OJ. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology 2004;231:880 - 6.
15. Research Committee, British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994;49:442 - 5.
16. Sauret J, Hern án dez-Flix S, Castro E, Herná n dez L, Ausina V, Coll P. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months ' chemotherapy. Tuber Lung Dis 1995;76:104 - 8.
17. Griffi th DE, Brown-Elliott BA, Wallace RJ. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003;37:1178 - 82.
18. Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB, Raz M, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999 - 2004. Chest 2006;129:771 - 6.
19. The Research Committee of the British Thoracic Society. Pulmonary disease caused by M. malmoense in HIV negative patients: 5-year follow-up of patients receiving standardized treatment. Eur Respir J 2003;21:478 - 82.